Want to see JP:3183 full AI Analyst Report?
3183 Stock Chart & Stats
¥1326.00
-¥7.00(-0.53%)
At close: 4:00 PM EST
¥1326.00
-¥7.00(-0.53%)
Day’s Range― - ―
52-Week Range¥1,175.00 - ¥1,527.00
Previous CloseN/A
Volume13.40K
Average Volume (3M)11.73K
Market Cap
¥37.55B
Enterprise Value¥22.68K
Total Cash (Recent Filing)¥15.93B
Total Debt (Recent Filing)¥713.06M
Price to Earnings (P/E)17.2
Beta0.68
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.13%
Share Statistics
EPS (TTM)76.01
Shares Outstanding30,503,310
10 Day Avg. Volume13,600
30 Day Avg. Volume11,726
Financial Highlights & Ratios
PEG Ratio2.30
Price to Book (P/B)1.64
Price to Sales (P/S)0.42
P/FCF Ratio14.12
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthExtremely low leverage and sizable equity give WIN-Partners durable financial flexibility. Minimal debt reduces interest burden and supports capital allocation for dividends, investments in distribution, or absorbing shocks, enabling resilience across business cycles.
Consistent Revenue GrowthSustained top-line momentum across multiple years indicates persistent market demand for insurance placement and advisory services. Consistent revenue growth supports scale benefits, steadier commission income and underpins predictable long-term earnings potential.
Durable Commission-based Business ModelA commission and renewal-fee model creates recurring, low-capital-intensity revenue streams. Renewal commissions and consulting fees provide ongoing cash generation and diversification across life and non-life products, supporting stable operating performance over time.
Bears Say
Cash-flow VolatilityFree cash flow swings and prior negative FCF indicate working-capital or timing sensitivity. Volatile cash conversion reduces predictability of funds for dividends, investment or M&A, and can force reliance on reserves despite reported earnings strength.
Thin And Slipping MarginsLow absolute margins and modest margin erosion limit the firm's buffer against cost rises or commission compression. Thin profitability constrains internal reinvestment and makes returns sensitive to small revenue or cost fluctuations, weakening long-term operating leverage.
Revenue Sensitivity To Distribution And Insurer TermsDependence on new-policy commissions, renewal rates and distributor productivity exposes revenue to sales cycles and changes in carrier commission policies. Structural shifts in distribution or insurer terms could materially affect top-line and recurring commission flows.
WIN-Partners Co., Ltd. News
3183 FAQ
What was WIN-Partners Co., Ltd.’s price range in the past 12 months?
WIN-Partners Co., Ltd. lowest stock price was ¥1175.00 and its highest was ¥1527.00 in the past 12 months.
What is WIN-Partners Co., Ltd.’s market cap?
WIN-Partners Co., Ltd.’s market cap is ¥37.55B.
When is WIN-Partners Co., Ltd.’s upcoming earnings report date?
WIN-Partners Co., Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 10 days.
How were WIN-Partners Co., Ltd.’s earnings last quarter?
WIN-Partners Co., Ltd. released its earnings results on May 15, 2026. The company reported ¥21.3 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is WIN-Partners Co., Ltd. overvalued?
According to Wall Street analysts WIN-Partners Co., Ltd.’s price is currently Overvalued.
Does WIN-Partners Co., Ltd. pay dividends?
WIN-Partners Co., Ltd. pays a Annually dividend of ¥55 which represents an annual dividend yield of 4.13%. See more information on WIN-Partners Co., Ltd. dividends here
What is WIN-Partners Co., Ltd.’s EPS estimate?
WIN-Partners Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does WIN-Partners Co., Ltd. have?
WIN-Partners Co., Ltd. has 30,503,310 shares outstanding.
What happened to WIN-Partners Co., Ltd.’s price movement after its last earnings report?
WIN-Partners Co., Ltd. reported an EPS of ¥21.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.482%.
Which hedge fund is a major shareholder of WIN-Partners Co., Ltd.?
Currently, no hedge funds are holding shares in JP:3183
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
WIN-Partners Co., Ltd.
Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.
Technical Analysis
Medley
―
―
Japan Hospice Holdings Inc.
―
Amvis Holdings.Inc.
―
Japan Medical Dynamic Marketing, Inc.
―